Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasmacytosis”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)WithdrawnNCT03196401
What this trial is testing

Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma

Who this might be right for
Solitary Bone Plasmacytoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01301807
What this trial is testing

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Non-Secretory Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)Ended earlyNCT02353572
What this trial is testing

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
University of Colorado, Denver 3